Updated Lipoprotein(a) Genomic Risk Score and Aspirin for Primary Prevention of Cardiovascular Events is a research paper published in JACC Advances (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Health and Medical Research Council
Grant: 1127060
ASPREE Completion Project
National Health and Medical Research Council
Grant: 334047
Randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged.
National Health and Medical Research Council
Grant: IG1173690
National Institutes of Health
Grant: U01AG029824
National Institutes of Health
Grant: U19AG062682
National Heart Foundation of Australia
Grant: 102604
National Institutes of Health
Grant: 5U19AG062682-04
ASPirin in Reducing Events in the Elderly - eXTension
National Institutes of Health
Grant: 4U01AG029824-06
ASPirin in Reducing Events in the Elderly
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals